A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Intravaginal Micronized Progesterone Capsules 600 mg Daily for Luteal Support in In-Vitro Fertilization
Clinical trial NCT01850030 · COMPLETED
Trial details
- NCT number
- NCT01850030
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2016-03-01
- Enrollment
- 1070
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.